The human REL proto-oncogene encodes a transcription factor in the nuclear factor (NF)-kB family. Overexpression of REL is acutely transforming in chicken lymphoid cells, but has not been shown to transform any mammalian lymphoid cell type. In this report, we show that overexpression of a highly transforming mutant of REL (RELDTAD1) increases the oncogenic properties of the human B-cell lymphoma BJAB cell line, as shown by increased colony formation in soft agar, tumor formation in SCID (severe combined immunodeficient) mice, and adhesion. BJAB-RELDTAD1 cells also show decreased activation of caspase in response to doxorubicin. BJAB-RELDTAD1 cells have increased levels of active nuclear REL protein as determined by immunofluorescence, subcellular fractionation and electrophoretic mobility shift assay. Overexpression of RELDTAD1 in BJAB cells has transformed the gene expression profile of BJAB cells from that of a germinal center B-cell subtype of diffuse large B-cell lymphoma (DLBCL) (GCB-DLBCL) to that of an activated B-cell subtype (ABC-DLBCL), as evidenced by increased expression of many ABC-defining mRNAs. Upregulated genes in BJAB-RELDTAD1 cells include several NF-kB targets that encode proteins previously implicated in B-cell development or oncogenesis, including BCL2, IRF4, CD40 and VCAM1. The cell system we describe here may be valuable for further characterizing the molecular details of REL-induced lymphoma in humans.
Introduction
The human c-rel proto-oncogene (REL) encodes a nuclear factor (NF)-kB family transcription factor. Misregulated REL is associated with B-cell malignancies in several ways (Gilmore et al., 2004) . Overexpression of REL protein can transform chicken lymphoid cells in vitro. Additionally, the REL locus is amplified in several types of human B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL), follicular and primary mediastinal lymphomas. Moreover, REL mRNA is highly expressed in de novo DLBCLs, and this elevated expression correlates with increased expression of many putative REL target genes (Rhodes et al., 2005) . Nevertheless, REL has not been shown to be oncogenic in any mammalian B-cell system, either in vitro or in vivo.
REL contains an N-terminal Rel homology domain, which mediates DNA binding, dimerization, nuclear localization and binding to its inhibitor IkB. The C-terminal half of REL contains a transactivation domain, which can be divided into two subdomains (Martin et al., 2001; Starczynowski et al., 2003) . Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of REL in chicken spleen cells (Starczynowski et al., 2003) . Similarly, v-Rel lacks a transactivation subdomain found in avian c-Rel, and this deletion contributes to the increased transforming activity of v-Rel compared with c-Rel (Gilmore, 1999) . In addition, deletions and mutations that alter the REL transactivation domain have been identified in a small percentage of human BCLs, and one such mutation can enhance the transforming activity of REL in chicken lymphoid cells Barth et al., 2003; Starczynowski et al., 2007) . Nevertheless, the role of REL in mediating oncogenesis in mammalian cells is not clear.
Here, we show that the overexpression of a REL mutant lacking transactivation subdomain 1 (RELDTAD1) enhances certain 'transformed' properties of the human B-lymphoma cell line, BJAB. Furthermore, RELDTAD1-transformed BJAB cells have an altered gene expression profile that is consistent with them having been converted to a more aggressive form of DLBCL. As such, these results are the first direct demonstration that REL can contribute to human B-cell oncogenesis and describe an in vitro system for studying oncogenic conversion of B-cell lymphoma.
Results

Overexpression of RELDTAD1 increases oncogenic properties of BJAB cells
A REL mutant (RELD424-490 or RELDTAD1) that is missing the first C-terminal transactivation subdomain has an enhanced ability to transform primary chicken spleen cells in vitro compared with wild-type REL (Starczynowski et al., 2003) . In an effort to establish a human cell assay for REL-induced oncogenesis, we first created an MSCV-based retroviral vector for expression of RELDTAD1; as a control for our experiments, we used the MSCV vector backbone that contains only the puromycin resistance gene ( Figure 1a ). Cells were plated at 10 5 cells per well and were counted each day following plating. (e) BJAB-MSCV cells (MSCV) and BJAB-RELDTAD1 cells (DTAD1) were treated with 1 mg/ml doxorubicin (DOX) for the indicated times and caspase-3 activity was measured or PARP cleavage was monitored by western blotting (bottom panel). For each cell type, caspase activity is relative to the activity seen with untreated cells at the same time point (1.0). Cell viability was measured after treatment with 1.0 mg/ml of doxorubicin at the indicated time points (right panel). Values are the averages of four (caspase-3 activity) or three experiments (cell viability), each carried out with triplicate samples.
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Retroviral stocks of MSCV and MSCV-RELDTAD1 were used to infect human B-lymphoma BJAB cells, and these cells were then selected for puromycin resistance to establish stable pools of retrovirally transduced cells. By western blotting, we identified a pool of MSCV-RELDTAD1-transduced cells that expresses high levels of RELDTAD1, which migrates faster than full-length endogenous REL (Figure 1b) . The expression of RELDTAD1 is B2.4-fold greater than endogenous REL, which is expressed at approximately equal levels in both MSCV-RELDTAD1-transduced cells and control MSCV-transduced cells. The expression of RELDTAD1 was stable during more than 6 months of continued passage of MSCV-RELDTAD1-transduced cells (not shown).
To determine whether overexpression of RELDTAD1 affects oncogenic properties of the BJAB cell line, we first compared the soft agar colony-forming abilities of MSCV-RELDTAD1 cells and MSCV-transduced cells. As shown in Figure 1c , BJAB-RELDTAD1 cells had an B2.3-fold increased ability to form colonies in soft agar as compared to BJAB-MSCV cells. Moreover, colonies formed by BJAB-RELDTAD1 cells were generally larger than those formed by BJAB-MSCV cells (not shown). Similarly, BJAB-RELDTAD1 cells had increased tumor-forming ability in SCID (severe combined immunodeficient) mice (Table 1) . Nevertheless, the growth rates of BJAB-MSCV and BJAB-RELDTAD1 cells in liquid media were similar (Figure 1d ). Doxorubin-induced activation of caspase-3 and cleavage of the caspase substrate, PARP, are delayed in BJAB-RELDTAD1 cells compared with BJAB-MSCV cells; however, there is no difference in the ability of doxorubicin to decrease viability in these two cell types (Figure 1e ).
RELDTAD1-expressing BJAB cells have increased nuclear REL protein activity
As a first step toward determining the basis for the enhanced transformed properties of BJAB-RELDTAD1 cells, we characterized RELDTAD1 protein in these cells. By biochemical subcellular fractionation, BJAB-RELDTAD1 cells showed increased nuclear REL protein-for both RELDTAD1 and endogenous REL-compared with BJAB-MSCV cells, in which the low level of endogenous REL is almost exclusively cytoplasmic ( Figure 2a ). As controls for these fractionation experiments, we show that two cytoplasmic proteins (CD40 and 14-3-3) and a nuclear protein (RNA polymerase) are exclusively present in their respective fractions in both cell types. Indirect immunofluorescence showed that BJAB-RELDTAD1 cells have increased overall REL staining compared with BJAB-MSCV cells and also have detectable nuclear REL staining (Figure 2b) , which is not seen in BJAB-MSCV cells. Nuclear extracts from BJAB-RELDTAD1 cells also have increased levels of NF-kB p50, but not of RelA (Figure 2c) .
BJAB-RELDTAD1 cells show increased NF-kB site DNA-binding activity compared with BJAB-MSCV cells (Figure 2d ). The kB site-binding activity in BJAB-RELDTAD1 cells was competed by the relevant unlabelled probe and was almost completely supershifted by anti-REL antiserum. Therefore, by three criteria, nuclear REL protein is increased in BJAB-RELDTAD1 cells compared with control BJAB-MSCV cells.
In coimmunoprecipitations from BJAB cells, REL and RELDTAD1 interact equally well with IkBa, suggesting that the changes in DNA binding and nuclear localization seen in BJAB-RELDTAD1 cells are not due to changes in association with IkB (Supplementary Figure S1 ).
The expression of many known REL/NF-kB target genes is increased in RELDTAD1-expressing BJAB cells We next compared the overall gene expression profiles of BJAB-RELDTAD1 cells and BJAB-MSCV cells by using an extensive human microarray, which contains over 41 000 probes, representing unique gene products. Using a twofold change and P-value o0.005 (Holloway et al., 2008) , we found that 538 mRNAs were decreased and 663 mRNAs were increased in BJAB-RELDTAD1 cells (Supplementary Table S1 ). The levels of 67 transcripts were increased at least 10-fold in BJAB-RELDTAD1 cells (Table 2 ). Serving as an internal control, REL mRNA showed B25-fold increased expression in BJAB-RELDTAD1 cells, presumably because the REL probe on the microarray can detect both endogenous REL and exogenous RELDTAD1 mRNA/cDNA.
Several mRNAs that show greatly elevated expression in BJAB-RELDTAD1 cells are known REL/NF-kB targets, including CXCR7 (77-fold increase), IRF4 (32-fold), CD44 (26-fold), VCAM1 (24-fold), chemokine CCL22 (21-fold) and the antiapoptotic protein BCL2 (13.5-fold). However, out of B400 reported REL/ NF-kB targets (see www.nf-kb.org), only B4% were Alizadeh et al., 2000; Rosenwald et al., 2002; Shipp et al., 2002; Wright et al., 2003; Ngo et al., 2006) . This division is based on the observation that one subset of DLBCLs has a gene expression profile similar to B lymphocytes in the germinal center, whereas another subset has a gene expression profile similar to activated peripheral B cells (Alizadeh et al., 2000) . Furthermore, the ABC subtype has increased expression of several NF-kB target genes compared with the GCB subtype, and survival of ABC cell lines depends on expression of these NF-kB target genes (Davis et al., 2001; Lam et al., 2008) . BJAB cells have a gene expression profile that is consistent with the GCB subtype Ngo et al., 2006) . Using the literature, we assembled a comprehensive set of genes that have been used to define these two subsets of DLBCL: 102 for ABC and 62 for GCB (see Supplementary Tables S2 and  S3 for details). We then compared the levels of these ABC-and GCB-defining targets between BJAB-MSCV cells and BJAB-RELDTAD1 cells, using a P-value o0.005 as a cutoff. Overall, 30% of the 102 ABC profile genes were upregulated in the BJAB-RELDTAD1 cells (Table 3 ). We also found that BJAB cells overexpressing RELDTAD1 showed increased expression of many of the ABC-defining genes that are NF-kB targets ( Figure 3a ): 17/29 (59%) ABC-specific NF-kB target genes were upregulated in BJAB-RELDTAD1 cells (Table 3) . Using the same filter criteria (Po0.005), only 6% of total transcripts showed increased expression in BJAB-RELDTAD1 cells compared with BJAB-MSCV cells.
We also found that 24% of the GCB-defining genes were downregulated in BJAB-RELDTAD1 cells compared with BJAB-MSCV cells (Table 3 ). In contrast, only 9% of the total transcripts were downregulated in BJAB-RELDTAD1 cells.
A statistical comparison of the percent change in ABC subtype genes (30% upregulated, 12% downregulated) versus GCB subtype genes (10% upregulated, 24% downregulated) in BJAB-RELDTAD1 cells (compared with BJAB-MSCV cells) indicates that these two gene sets are affected in a significantly different manner (P-value, 0.0009; see Table 3 ). 
Figure 2 BJAB-RELDTAD1 cells have increased nuclear REL protein activity compared with BJAB-MSCV cells. BJAB-RELDTAD1 and BJAB-MSCV cells were compared by subcellular fractionation (a, c), indirect immunofluorescence using an anti-REL primary antiserum (b) and by EMSA analysis of nuclear extracts (d). In (a) and (c), nuclear (N) and cytoplasmic fractions (C) were subjected to western blotting using equal proportions of each fraction for analysis of REL, p50, RelA and 14-3-3 and CD40 proteins (as cytoplasmic controls) or RNA polymerase II (as a nuclear control). In panel b, the indicated BJAB cells were stained with an anti-REL antibody and viewed by confocal microscopy. The left panel contains BJAB-RELDTAD1 cells; the middle and right panels show BJAB-MSCV cells. The left and middle panels were imaged using the same exposure time (Exp), whereas the right panel was imaged using a longer exposure time to detect the low level of endogenous REL in BJAB-MSCV cells. In panel d, an EMSA was carried out on equalized amounts (5 mg) of nuclear extracts using a kB site probe from the human MHC1 enhancer. Where indicated, competitions were carried out using an excess of cold probe or samples were supershifted using anti-REL antiserum.
The relevant complexes are indicated. Abbreviations: ABC, activated B-cell subtype; NF-kB, nuclear factor-kB. a ABC gene refers to a gene classified as being overexpressed in ABC-DLBCL (Alizadeh et al., 2000; Shipp et al., 2002; Wright et al., 2003; Feuerhake et al., 2005; Ngo et al., 2006) . b NF-kB targets are obtained from www.nf-kb.org.
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To further analyse our gene expression data, we used Gene Ontology (http://david.abcc.ncifcrf.gov/) to categorize genes upregulated in BJAB-RELDTAD1 cells. We focused on upregulated genes because REL is primarily a transcriptional activator. Using this analysis, we were able to classify 563 of the 663 upregulated genes (>2-fold, Po0.005) in BJAB-RELDTAD1 cells; many of these upregulated genes encode proteins associated with cell surface processes/regions, including ones involved in cell-cell communication, the plasma membrane, the extracellular matrix, biological adhesion and signal transduction in general (Table 4) .
In addition, we classified this same set of upregulated genes in BJAB-RELDTAD1 cells by their biological function (www.ingenuity.com); by this analysis, we were able to classify 421 of 663 significantly upregulated genes. This analysis was consistent with our Gene Ontology annotation. Namely, over-represented molecular and cellular functions included those involved in cell-to-cell communication and cell growth and proliferation (Table 4) . Furthermore, many genes (75 out of 421 annotated) that are statistically over-represented have been associated with immunological diseases (Table 4) .
We next used reverse transcriptase PCR to validate a subset of genes showing increased expression in BJAB-RELDTAD1 cells. As controls, we used a primer set that could amplify both endogenous REL and RELDTAD1 to show that REL mRNA expression is increased in BJAB-RELDTAD1 cells compared with BJAB-MSCV cells, whereas GAPDH expression is similar in both cell types (Figure 3b) . Consistent with the microarray results, there was increased expression of BCL2, CCR7, IRF4 and VCAM1 mRNA in BJAB-RELDTAD1 cells. In contrast, CD10, a marker for GCB-type DLCBL (van Imhoff et al., 2006) , showed reduced mRNA expression in BJAB-RELDTAD1 cells. Western blotting showed that protein levels of BCL2, VCAM1, CD40 and REL are all elevated in BJAB-RELDTAD1 cells (Figure 3c ), whereas CD10 protein is reduced in BJAB-RELDTAD1 cells (Figure 3c ). For CD40, the small (1.4-fold), but significant (Pp8.97 Â 10 À11 ), increase in CD40 mRNA in BJAB-RELDTAD1 cells seen on the microarray was mirrored by an B1.4-fold increase in CD40 protein.
BJAB-RELDTAD1 cells show increased adherence to culture dishes During passage, we noticed that BJAB-RELDTAD1 cells appeared to adhere more readily to culture plates BCL2L1  ICAM1  EGR1  LTA  CD40  NFKB2  NFKB1A  MYC  CCNDA  TNFA  PIM1  TRAF2  IL2RA  A20/TNFAIP3  IGHG1  BLNK  MAPK4  IL6  - Abbreviations: ABC, activated B-cell subtype; GCB, germinal center B-cell; NF-kB, nuclear factor-kB. Gene lists were obtained using previously classified ABC and GCB-specific genes (Alizadeh et al., 2000; Rosenwald et al., 2002; Wright et al., 2003; Feuerhake et al., 2005; Ngo et al., 2006) and NF-kB targets were obtained from www.nf-kb.org. See Supplementary Table S2 and S3 for complete gene lists, references and annotations. Listed are the numbers of genes that are upregulated, downregulated or unchanged in RELDTAD1 cells compared with BJAB-MSCV cells within a given subset. The genes with altered expression were classified based on a P-value cutoff of 0.005. Genes were grouped into ABC-specific genes, ABC-specific NF-kB targets, GCB-specific genes and GCB-specific NF-kB target genes. To validate the patterns of ABC and GCB gene expression distribution in BJAB-RELDTAD1 cells, we calculated the P-value of the two gene sets (ABC, 31 and 12 versus GCB, 6 and 15) using a two-tailed w 2 -test at 95% confidence using Graphpad Prism 4 software (Graphpad Prism Software, San Diego, CA, USA). These two gene sets differed with a highly significant P-value (0.0009). That is, the percentage of upregulated ABC genes and the percentage of downregulated GCB genes in BJAB-RELDTAD1 cells are significantly different from one another.
than BJAB-MSCV cells. To compare the abilities of BJAB-MSCV and BJAB-RELDTAD1 cells to adhere, we plated both cell types on Petri dishes, and cultured the cells for 36 h. We then visualized these cells before and after washing with phosphate-buffered saline. As shown in Figure 4a , many BJAB-RELDTAD1 cells remained attached to the culture dish after washing, whereas the BJAB-MSCV cells were removed by washing. We quantified this difference in adherence by comparing the numbers of floating versus adhering cells for each cell type: Bfivefold more BJAB-RELDTAD1 cells were attached to the dish compared with the BJAB-MSCV cells (Figure 4b ). BJAB cells have low levels of endogenous REL protein expression BJAB cells have previously been shown to have a low level of REL mRNA compared with a number of other lymphoma cell lines (Leeman et al., 2008) . To determine whether REL protein expression was also low in BJAB cells, we compared the expression of endogenous REL protein in BJAB cells to five other human BCL cell lines (SUDHL-4, RC-K8, IB4, BL41 and Daudi). SUDHL-4 cells have been characterized as having a GCB profile, whereas RC-K8 cells have an ABC cDNA expression profile . Among these six lymphoma cell lines, the expression of REL was lowest in BJAB cells (Figure 5a ). As such, in BJAB cells, retrovirally transduced expression of RELDTAD1 is higher than endogenous REL, whereas in Daudi cells, RELDTAD1 expression is lower than endogenous REL (Figure 5b) . Moreover, expression of RELDTAD1 did not enhance the soft agar colony ability of Daudi cells (Figure 5c ), at least when expressed at the level in the cell line that we analysed here.
Discussion
This study represents the first direct demonstration of an oncogenic effect of REL protein expression in a human B-lymphoid cell system. That is, we show that overexpression of an activated REL mutant, RELDTAD1, increases the oncogenic properties of the human B-cell lymphoma BJAB cell line, as measured by increased soft agar colony-forming ability, tumor formation in immunocompromized mice and adhesion. Moreover, the mRNA expression profile of BJAB cells overexpressing RELDTAD1 is substantially altered; in particular, there is increased expression of many NF-kB target genes whose expression is associated with the more aggressive ABC subtype of DLBCL. Furthermore, many of the upregulated genes in BJAB-RELDTAD1 cells can be classified as genes implicated in immunological diseases (Table 4 ), suggesting that BJAB-RE-LDTAD1 cells have a phenotype that is more similar to aggressive DLBCL than is the GCB-like phenotype of control BJAB cells.
R E L
As such, the cell system that we describe here may provide an in vitro model system for understanding DLBCL transition from a low-grade (GCB-like) to a high-grade (ABC-like) oncogenic state.
Although v-Rel, c-Rel and their derivatives have been shown to be oncogenic in avian and mouse systems (Gilmore, 1999; Gilmore et al., 2004) , there has been controversy about whether REL is a true oncoprotein for human B-lymphoid cells (Shaffer et al., 2002; Houldsworth et al., 2004) . For example, the REL gene is amplified in a high percentage of GCB-type DLBCLs, but these cells do not have particularly high levels of NF-kB site-binding activity (Davis et al., 2001) . Moreover, the lack of oncogenic activity by overexpressed REL in mouse B-lymphoid cells in vitro or in vivo has cast doubt on whether REL acts as an oncoprotein in human B-cell malignancies, which are the sole human cancer cell type wherein the REL gene has been found to undergo amplification and mutation (Gilmore et al., 2004) . The results we present herein strongly suggest that REL can exert an oncogenic effect in human Blymphoma cells, and indicate that REL or certain REL target genes may be suitable therapeutic targets for some human B-cell lymphomas.
There are several likely explanations for the susceptibility of BJAB cells to the transforming activity of RELDTAD1. First, BJAB cells express relatively low levels of endogenous REL protein ( Figure 5a ) compared with several other human B-lymphoma cell lines. Thus, in BJAB cells, it is possible to achieve a higher ratio of RELDTAD1 protein to endogenous REL, and this relatively high level of RELDTAD1 may be required for its transforming effect in human B cells. Second, BJAB cells have a GCB mRNA profile (Ngo et al., 2006) , which is correlated with a better clinical outcome in DLBCL patients Shipp et al., 2002) , suggesting that BJAB cells are not as 'transformed' as some other human B-cell lines. Third, in soft agar and tumor-forming assays similar to those we have conducted here, BJAB cells have been shown to be susceptible to oncogenic effects of other factors, including the EBV (Epstein-Barr virus) LMP1 protein (Enberg et al., 1983; Wennborg et al., 1987) , EBV small RNAs (Yamamoto et al., 2000) and the AP12-MALT1 fusion protein from MALT lymphomas (Ho et al., 2005) . Interestingly, LMP1 and AP12-MALT1 are both inducers of NF-kB (Hammarskjold and Simurda, 1992; Lucas et al., 2007) , and both can increase the resistance of BJAB cells to inducers of apoptosis (Stoffel et al., 2004; Ho et al., 2005) . In addition, LMP1 can induce expression of BCL2 and IRF4, which are required for apoptosis resistance (Henderson et al., 1991; Finke et al., 1992; Snow et al., 2006) , enhanced adhesion (Mainou and Raab-Traub, 2006 ) and cell motility (Mainou and Raab-Traub, 2006) . Moreover, MALT1 chromosomal gains are also associated with ABC subtype gene expression, including high levels of BCL2 expression and poorer prognosis (Dierlamm et al., 2008) .
Many of the upregulated genes in BJAB-RELDTAD1 cells are implicated in processes that involve the plasma membrane, that is, cell-to-cell communication, the extracellular matrix, adhesion and membrane binding (see Table 4 ). These genes include VCAM1, CD44, CD40, ITGAX and many chemokines and chemokine receptors, including CCL22, CCR7, CXCR4 and CXCL10. Additionally, BJAB-RELDTAD1 cells are more adherent to a culture dish than control BJAB-MSCV cells (Figure 4 ). This is consistent with the large cohort of increased cDNAs in RELDTAD1 cells that are classified as related to adhesion (Table 4) . NF-kB signaling is also known to be downstream of many adhesion-related signaling pathways (Perez et al., 1994; Lee et al., 1999; Zarnegar et al., 2004) . Furthermore, CD40 and VCAM1 mRNA and protein expression are upregulated in the BJAB-RELDTAD1 cells. Although CD40 mRNA was only modestly increased (1.4-fold) in BJAB-RELDTAD1 cells, this did translate into similarly increased CD40 protein levels ( Figure 3c ). CD40 has been shown to be important in B-cell aggregation (Lee et al., 1999) , and both VCAM1 and CD40 play roles in adhesion (Springer and Vonderheide, 1992; Lee et al., 1999) . Taken together, these results suggest that overexpression of RELDTAD1 in BJAB cells causes upregulation of many adhesion-associated genes, which results in a phenotype of the cells being more adherent, which may contribute to their enhanced ability to form colonies in soft agar and tumors in SCID mice. BCL2 and IRF4 genes, whose expression is upregulated in BJAB-RELDTAD1 cells, are markers for ABC DLBCL, whereas CD10 is downregulated in both ABC DLBCLs and BJAB-RELDTAD1 cells (Alizadeh et al., 2000; Wright et al., 2003) . The increased expression of BCL2 in ABC DLBCLs correlates with a poorer clinical prognosis (Iqbal et al., 2006) . The transcription factor IRF4 can synergize with v-Rel in the transformation of chicken fibroblasts and knockdown of IRF4 expression reduces the soft agar colony-forming ability of v-Rel-transformed cells (Hrdlicˇkova´et al., 2001) . Of note, multiple myelomas are dependent on IRF4 for growth, whereas the growth of GCB-DLCBL does not require IRF4 (Shaffer et al., 2008) . Taken together, these results are consistent with BCL2 and IRF4 playing a role in the enhanced transformed phenotype that we describe for BJAB-RELDTAD1 cells.
We also found that many other ABC-defining genes (including several not known to be NF-kB targets) are significantly upregulated in BJAB-RELDTAD1 cells. These ABC genes include MARCKS, BATF, BMI1, LITAF and others (see Table 2 and Supplementary Table  S2 ). Some of these ABC-type upregulated genes may reflect an overall shift in gene expression, induced indirectly by NF-kB/REL. In addition, some GCB subtype genes are significantly downregulated in BJAB-RELDTAD1 cells (Table 3 and Supplementary Table S3) . These genes are, for the most part, non-NF-kB targets, suggesting that these decreases in GCB-type gene expression are also indirectly affected by RELDTAD1.
Approximately 4% of total NF-kB targets (www. nf-kb.org) were upregulated in BJAB-RELDTAD1 cells compared with 59% of ABC-specific NF-kB targets ( Table 2 ). The selective increase in expression of only a small number of NF-kB target genes in BJAB-RELDTAD1 cells suggests that the BJAB cells have been transformed to a more aggressive form of DLBCL by RELDTAD1 through activation of a minor subset of NF-kB/REL targets. These ABC-specific NF-kB target genes may be poised for activation by RELDTAD1 in B-lymphoma cells, possibly due to their chromosomal state or to co-operation of RELDTAD1 with other B-cell-specific transcription factors.
There are 40 genes whose expression is reduced by at least 10-fold in BJAB-RELDTAD1 cells (Supplementary Table S1 ). The reduced expression of CD10 mRNA and protein in BJAB-RELDTAD1 cells (Figure 3) is consistent with the enhanced transformed properties of these cells, given that reduced CD10 expression correlates with a poorer prognosis in the clinic (van Imhoff et al., 2006) . Gupta et al. (2008) have shown that expression of two B-cell proteins, BLNK and BCAP, are downregulated directly by Rel in v-Rel-transformed avian cells. In our study, the level of only BLNK was significantly reduced in BJAB-RELDTAD1 cells. Such results raise the possibility that the downregulation of gene expression is important for REL-induced effects on B-cell oncogenesis, and that some downregulated genes are specifically repressed by RELDTAD1.
BJAB-RELDTAD1 cells show a reduced induction of caspase-3 activity following treatment with 1 mg/ml doxorubicin, although the ability of doxorubicin to decrease viability is unchanged in BJAB-RELDTAD1 cells (Figure 1e ). These data are consistent with earlier results showing that CD40 ligand, an inducer of NF-kB, can reduce the ability of this concentration of doxorubicin to induce caspase activity in BJAB cells without affecting its ability to induce apoptosis (VoorzangerRousselot et al., 1998) . These results indicate that doxorubicin induces apoptosis in BJAB cells through a caspase-independent mechanism, which is not blocked by increased Rel/NF-kB activity.
The majority of the NF-kB site-binding activity in RELDTAD1-BJAB cells contains REL protein, whereas in control BJAB-MSCV cells, only a small fraction of the binding activity is supershifted by REL antiserum (Figure 2d ). In addition, there are increased nuclear levels of NF-kB p50 in BJAB-RELDTAD1 cells, presumably because RELDTAD1 and p50 readily interact (Supplementary Figure S1) . Taken together, these data suggest that a shift in the composition of NF-kB/REL dimers occurs upon overexpression of RELDTAD1.
Only a small number of the genes upregulated by more than 10-fold in BJAB-RELDTAD1 cells are ABCdefining genes (five genes) or known NF-kB targets (eight genes; Table 2 ). As such, some of these genes may be novel ABC DLBCL markers or NF-kB/REL targets. In addition, there are 14 ABC-defining genes that are significantly upregulated in BJAB-RELDTAD1 cells that have yet to be classified as NF-kB/REL targets (Table 3 and Supplementary Table S2) . Future studies will be directed at determining which genes are direct RELDTAD1 targets and which contribute to the phenotypic changes that occur in RELDTAD1 'transformed' BJAB cells.
Materials and methods
Plasmids, cell culture and infections. pMSCV has been described earlier . pMSCV-RELDTAD1 was created by subcloning a BglII to XhoI fragment containing the RELDTAD1 cDNA into pMSCV.
Human A293 T cells and BJAB or Daudi lymphoma cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10 or 20% fetal bovine serum (Biologos, Montgomery, IL, USA), respectively, as described (Starczynowski et al., 2005) . Virus stocks were generated by transfecting A293T cells with pMSCV or pMSCV-RELDTAD1 plus helper plasmid pcL10a1, essentially as described earlier . Approximately 2 days later, virus was harvested; 1 ml of virus (in the presence of 4 mg/ml polybrene) was used to infect 10 6 BJAB or Daudi cells using the spin infection method . Two days later, cells were selected with 2.5 mg/ml puromycin (Sigma, St Louis, MO, USA) for 2-4 weeks.
Soft agar colony-and tumor-formation assays For soft agar assays, equal numbers of the indicated BJAB or Daudi cells (250, 500, 1000 or 2000 cells) were placed in soft agar containing Dulbecco's modified Eagle's medium, 20% fetal bovine serum and 0.3%. bacto agar (Difco, Franklin Lakes, NJ, USA), and plates were placed at 37 1C in a humid incubator with 5% CO 2 . To confirm cell counts, total cell protein assays (Bio-Rad, Hercules, CA, USA) were carried out on the cell dilutions used for plating. Macroscopic soft agar colonies were counted 14 days after plating.
Tumor studies were carried out essentially as described earlier (Yamamoto et al., 2000; Gapuzan et al., 2002) . A total of 5 Â 10 6 cells were injected subcutaneously into SCID mice (Taconic Farms, Germantown, NY, USA). Once tumors appeared, mice were monitored 3 times weekly and animals were killed when tumors reached 2.25 mm 2 . All animal studies were carried out in accordance with National Institutes of Health guidelines and with the approval of the Boston University Institutional Animal Care and Use Committee.
Caspase-3 and cell viability assays Caspase-3 activity and cell viability following doxorubicin treatment were carried out as described in Supplementary material.
Western blotting, indirect immunofluorescence, biochemical fractionation and electrophoretic mobility shift assays Western blotting and indirect immunofluorescence were carried out as described earlier (Starczynowski et al., 2003 (Starczynowski et al., , 2005 . Details of antisera are in Supplementary material.
Indirect immunofluorescence was visualized using a confocal microscope (Olympus FLUOVIEW Laser Scanner Microscope BX 50, Center Valley, PA, USA; Starczynowski et al., 2003) .
Cytoplasmic and nuclear extracts were prepared as described earlier (Liang et al., 2003) , and were used either for western blotting of equalized fractions or in electrophoretic mobility shift assays (nuclear extracts). EMSAs for kB sitebinding were carried out using 5 mg of nuclear extracts as described previously . For supershift assays, 1 ml of REL antiserum (no. 1507, gift of Nancy Rice) was added after protein/DNA complex formation, and samples were then incubated for an additional hour on ice .
mRNA analysis: microarrays, data analysis and reverse transcriptase PCR The Agilent Whole Human Genome Microarray platform (product number G4112, Agilent Technology, Santa Clara, CA, USA). This array contains 43 376 human oliognucleotide probes and also 1468 positive controls and 153 negative controls. Within the array, there are B41 000 unique probes, which represent a smaller number of genes, reflecting the redundancy of the array platform. RNA was isolated from B5 Â 10 6 BJAB-MSCV and BJAB-RELDTAD1 cells from four separate dishes for each on four separate days using Trizol reagent (Invitrogen, Carlsbad, CA, USA). RNA integrity was measured using an Agilent 2100 Bioanalyzer (Agilent Technology), and all samples had integrity values over 8.0. Samples from two RNA aliquots for each cell type were pooled, creating four pooled RNA samples: two of BJAB-MSCV and two of BJAB-RELDTAD1 cells. Sample labeling, hybridization to microarrays, scanning and calculation of normalized expression ratios were carried out as described earlier (Holloway et al., 2008) at the Wayne State University Institute of Environmental Health Sciences microarray facility. As part of the platform, a dye swapping experiment was carried out, where Alexa 555-labeled cDNA from one of the BJAB-MSCV pools was mixed with Alexa 647-labeled cDNA from one of the BJAB-RELDTAD1 pools. In a reciprocal dye swap, Alexa 647-labeled cDNA from BJAB-MSCV cells was mixed with Alexa 555-labeled cDNA from BJAB-RELDTAD1 cells.
The false discovery rate was calculated as described earlier (Clodfelter et al., 2007) . Briefly, a filter of Po0.005 was applied for statistical significance. Of the total probes on the array, 1592 met the twofold expression difference cutoff criterion between the two cell types. The number of genes predicted to meet the combined threshold (Po0.005 and a greater than twofold change in expression) by type I errors is 0.005 Â 1592, or eight genes. In our array, the actual number of genes having a twofold expression change and a Po0.005 is 1274. This corresponds to an FDR of 0.63% (8/1274). To eliminate duplicates in this analysis, we removed those genes with identical sequence names.
Reverse transcriptase PCR was carried out as described (Leeman et al., 2008) . See Supplementary Material for details of primers and PCR conditions. Adhesion assay BJAB-MSCV and BJAB-RELDTAD1 cells (1 Â 10 6 ) were plated on Petri dishes and were cultured for 36 h at 37 1C and imaged. Cells were then washed once with phosphate-buffered saline and the same field was imaged again using the same magnification ( Â 200). To quantify the number of attached and floating cells, cells from triplicate dishes of each cell type were also isolated directly from the media and cells that remained adhered were collected separately. Both pools of cells were then lysed, and total protein was quantified from these lysates. 
